Free tool
FDA Clearance Tracker
Last checked: Nov 19, 2026Latest source record: Nov 8, 2026 (newest decision)openFDA last updated: Nov 9, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Product code NIG: System, Test, Carbohydrate Antigen (Ca19-9), For Monitoring And Management Of Pancreatic Cancer. Open this device type's page
4 decisions
product code NIG. Showing 1 to 4, newest first. PMA results are original approvals and panel-track supplements.
- Atellica IM CA 19-9 II510(k)
Siemens Healthcare Diagnostics, Inc.
K253528 · Decided Aug 10, 2026 · 270 days after receipt
Device type: System, Test, Carbohydrate Antigen (Ca19-9), For Monitoring And Management Of Pancreatic Cancer (NIG) · Laboratory Medicine & Pathology
K231525 · Decided Aug 9, 2023 · 75 days after receipt
Device type: System, Test, Carbohydrate Antigen (Ca19-9), For Monitoring And Management Of Pancreatic Cancer (NIG) · Laboratory Medicine & Pathology
- Lumipulse G CA19-9-N510(k)
K200997 · Decided May 14, 2020 · 28 days after receipt
Device type: System, Test, Carbohydrate Antigen (Ca19-9), For Monitoring And Management Of Pancreatic Cancer (NIG) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.